Trial Search Results

Myoelectric GutPrint-Crohn's Disease

A feasibility study for assessing and recording myoelectric activity in patients for early detection of flare in patients with Crohn's disease and differentiating the myoelectric signals from Crohn's disease patients in remission state and healthy controls.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: The Leona M. and Harry B. Helmsley Charitable Trust

Stanford Investigator(s):

Intervention(s):

  • Device: G-Tech Gutcheck Myoelectric recording device

Eligibility


Inclusion Criteria:

   - Patients with Crohn's disease and healthy subjects above the age of 18 who are able to
   give consent and follow direction.

Exclusion Criteria:

   - Patients or subjects under the age of 18, pregnant, and those unable to give consent
   or follow direction.

   - Healthy subjects with gastrointestinal symptoms or history of gastrointestinal
   surgeries.

   - Patients with severe Crohn's disease due to complexity of disease, complication, and
   potential needs for surgery.

   - Patients with bowel surgeries due to potential impact on the G-Tech results. For
   similar reasons we will exclude patients on new medications (e.g. within 3 months of
   enrollment) known to alter GI motility but we will not exclude patients on stable
   doses or chronic GI motility agents as this mimics "real world" in which the G-Tech
   patch will be used and we can learn the stability of the motility recordings over time
   in stable patients.

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sidhartha Sinha, MD
Recruiting